Aspartate aminotransferase

There are 435 papers on aspartate aminotransferase in aging research: 79 trials and 186 observational studies in people, 117 in animals, 1 in cells, 45 reviews. The newest story, Nov 9, 2026: “Gene variants linked to higher odds of fatty liver disease”.

Biomarker

435 papers study it67 more mention it54 findings

MeSH

46 new papers in 30 daysSee all 502 papers on aspartate aminotransferase

At a glance

Aspartate aminotransferase is linked with mortality and Alzheimer's disease in human observational studies; low levels are also linked with mortality in men. Studies disagree on links with vascular dementia, and a study finds no clear link with Alzheimer's brain pathology.

54 findings in 51 papers from 2005 to 2026, 12 of them since April 2026

“Worse cognition was positively correlated with AST, AST to ALT ratio, direct bilirubin (DBil), and GGT;”
Associations of liver dysfunction with incident dementia, cognition, and brain structure: A prospective cohort study of 431 699 adultsJournal of neurochemistry2023doi:10.1111/jnc.15988
  • Human trial79
  • Humans186
  • Animals117
  • Cells1

Interventions

16

Taurine

downin humans2

2 studies
  1. Taurine decreases aspartate aminotransferase in humans (versus placebo, in liver transplant recipients).

    “The taurine group had significantly greater reductions in aspartate aminotransferase (AST), total bilirubin, and international normalized ratio (INR).”

    Human trialversus placebo, in liver transplant recipientsliver2 g/day30 daysn = 169

    Could taurine supplementation improve graft functions after liver transplantation? A randomized clinical trial among liver transplant recipients

    Clinical nutrition ESPEN

  2. Taurine decreases aspartate aminotransferase in adults with short-bowel syndrome on long-term parenteral nutrition.

    “There was a significant decrease in aspartate aminotransferase level.”

    Human trialin adults with short-bowel syndrome on long-term parenteral nutritiontaurine-enriched parenteral nutrition6.0 (SE 0.6) mg/kg per d55 (SE 13) monthsn = 10

    Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study

    The British journal of nutrition

More on Taurine

Curcumin

upin humans1downin humans1

2 studies
  1. Curcumin increases aspartate aminotransferase in humans.

    “Conversely, AST levels significantly increased in the curcumin group from 30.5 (24.25–38) to 36 (25.5–48.5) (p = 0.028), while mean AST level was not increased significantly in the placebo group (pre-intervention: 29 (25–33) to post intervention: 31 (30–35) (p = 0.191)).”

    Human trial12 weeksn = 14

    Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial

    Nutrients

  2. Curcumin decreases aspartate aminotransferase in NAFLD patients (MD = - 7.43, 95% CI (- 11.31, - 3.54)).

    “Curcumin was more likely to lower LDL-C, triglycerides, FBS, HOMA-IR, weight and AST levels compared with placebo, and the difference was statistically significant”

    Reviewin NAFLD patientsn = 229

    The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

    Hepatology international

More on Curcumin

Ubiquinol

no changein humans1

1 study
  1. Ubiquinol showed no clear effect on aspartate aminotransferase.

    “In contrast, we found no alteration of AST activity in response to Q10H2 supplementation.”

    Human trial14 daysmalesn = 53

    Ubiquinol reduces gamma glutamyltransferase as a marker of oxidative stress in humans

    BMC research notes

  2. Ubiquinol showed no clear effect on aspartate aminotransferase in humans (cohort II).

    “Of note, other liver enzymes (i.e., aspartate aminotransferase, AST) were not affected by Q10H2 supplementation.”

    Human trialcohort II150 mg/d14-daymalesn = 53

    Ubiquinol reduces gamma glutamyltransferase as a marker of oxidative stress in humans

    BMC research notes

More on Ubiquinol

Apple and apple-derived products

downin humans1

1 study
  1. Apple and apple-derived products decrease aspartate aminotransferase in humans (WMD −1.56 IU/L; p = 0.006).

    “However, a significant reduction was observed for AST (WMD: −1.56 IU/L; p = 0.006).”

    Reviewserum

    Effects of Apple and Apple‐Derived Products on Serum Inflammatory Biomarkers, Adiponectin, and Liver Enzymes in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

    Food science & nutrition

More on Apple and apple-derived products

Alpha-synuclein preformed fibrils

upin mice1

1 study
  1. Alpha-synuclein preformed fibrils increase aspartate aminotransferase in mice (gut-origin PD mouse model, 8 months after injection).

    “serum aspartate aminotransferase (AST) and AST/ALT ratio increased”

    Animalsgut-origin PD mouse model, 8 months after injectionpreformed fibrils8 months

    Pathological α-synuclein propagation via the gut-liver axis induces liver injury in gut-origin Parkinson's disease mouse models

    Experimental neurology

More on Alpha-synuclein preformed fibrils

Exercise

downin humans1

1 study
  1. Exercise decreases aspartate aminotransferase in humans.

    “Furthermore, post-treatment SGOT and SGPT concentrations were markedly lower in the experimental arm, confirming a more robust normalization of liver enzymes following the exercise protocol.”

    Human trial12 weeksn = 40

    Effect of an Integrated Exercise Training Program on Muscle Mass and Functional Capacity in Sarcopenic Patients With Decompensated Liver Cirrhosis

    Cureus

More on Exercise

Vaccinium macrocarpon

upin humans1

1 study
  1. Vaccinium macrocarpon increases aspartate aminotransferase in adults over 50 years, overweight individuals, and treated for >8 weeks.

    “Conversely, cranberry intake was also linked to a significant increase in AST levels within these subgroups.”

    Reviewin adults over 50 years, overweight individuals, and treated for >8 weeks

    The Effect of Cranberry Consumption on Body Weight and Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Food science & nutrition

More on Vaccinium macrocarpon

Resveratrol

upin rats1

1 study
  1. Resveratrol increases aspartate aminotransferase in rats.

    “Plasma AST showed a significant dose-related increase after FDR correction (q = 0.0445)”

    Animalsoral gavageliver21 daysfemales

    Dose-Dependent Hepato-Renal Histopathology and Inflammatory Signaling Changes After Subacute Oral Resveratrol Exposure in Healthy Female Rats

    Journal of applied toxicology : JAT

More on Resveratrol

Unhealthy dinner dietary pattern

upin humans1

1 study
  1. Unhealthy dinner dietary pattern is linked with higher aspartate aminotransferase in humans (patients with NAFLD) (p = 0.030).

    “More adherence to unhealthy dinner dietary patterns was also associated with an increase in AST concentration (p = 0.030).”

    Humanspatients with NAFLDn = 280

    Identification of dinner dietary patterns and their association with metabolic risk factors and anthropometric indices in adults with non-alcoholic fatty liver disease

    BMC nutrition

More on Unhealthy dinner dietary pattern

Resistance training

no changein humans1

1 study
  1. Resistance training showed no clear effect on aspartate aminotransferase in humans (MASLD/NAFLD) (MD -0.18 U/L, 95% CI -6.70 to 6.34).

    “No significant difference was observed in aspartate aminotransferase (AST) levels (MD = -0.18 U/L, 95% CI = -6.70 to 6.34, Z = 0.05, P = 0.96).”

    ReviewMASLD/NAFLD

    Resistance training for metabolic dysfunction-associated steatotic liver disease:a systematic review and meta-analysis

    Frontiers in physiology

More on Resistance training

Vitamin E

downin humans1

1 study
  1. Vitamin E decreases aspartate aminotransferase in humans (P = 0.007).

    “aspartate aminotransferase (P = 0.007), while it increased high-density lipoprotein cholesterol (P = 0.005)”

    Human trialcapsules200 IU twice/dailyeight weeksfemales

    Curcumin and vitamin E improve hot flashes, lipid profile, and fasting blood glucose without any detrimental effect on the liver and renal function in postmenopausal women: A triple-blind placebo-controlled clinical trial

    Health care for women international

More on Vitamin E

Coenzyme Q10

downin humans1

1 study
  1. Coenzyme Q10 decreases aspartate aminotransferase in humans (versus placebo).

    “waist circumference (WC) and serum AST and TAC concentrations significantly decreased in intervention group (p <0.05)”

    Human trialversus placebocapsules100 mg/day4 weeksn = 22

    Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress

    Archives of medical research

More on Coenzyme Q10

All 16

Effects

3

Carotid intima-media thickness

no changein humans1

1 study
  1. Aspartate aminotransferase was not clearly linked with carotid intima-media thickness in NAFLD patients (p<0.327).

    “but not with AST levels (p<0.327)”

    Humansin NAFLD patients

    Study of Carotid Atherosclerosis in Non-alcoholic Fatty Liver Disease Patients and Its Correlation With Serum Transaminases

    Cureus

More on Carotid intima-media thickness

Alzheimer's disease brain pathologies

no changein humans1

1 study
  1. Aspartate aminotransferase was not clearly linked with Alzheimer's disease brain pathologies in humans.

    “AST alone showed no significant association with changes of AD pathologies.”

    Humansbrainn = 347

    Liver function and Alzheimer's brain pathologies: A longitudinal study: Liver and Alzheimer's pathologies

    The journal of prevention of Alzheimer's disease

More on Alzheimer's disease brain pathologies

Vascular dementia

no changein humans1

1 study
  1. Aspartate aminotransferase was not clearly linked with vascular dementia in humans (univariable and multivariable Mendelian randomization).

    “no significant links were observed between ALT, AST, ALP, and all-cause dementia, VaD, AD, or FTD”

    Humansunivariable and multivariable Mendelian randomization

    Liver enzyme and risk of vascular dementia: A univariable and multivariable Mendelian randomization of European descent

    Neuroprotection (Chichester, England)

More on Vascular dementia

Upstream

1

Age

no changein humans1

1 study
  1. Age was not clearly linked with aspartate aminotransferase in humans (excluding subjects with known liver disease).

    “No such associations were noted for aspartate aminotransferase (AST) activity.”

    Humansexcluding subjects with known liver disease

    Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern

    The American journal of gastroenterology

Associations

26

Mortality

upin humans3mixedin humans1downin humans1HR 1.02–1.09

5 studies
  1. Aspartate aminotransferase is associated with mortality in humans.

    “AST exhibited a U-shaped association with mortality risk.”

    Humans1.5 yearsn = 22,758

    Prospective association between liver biomarkers and mortality risk in Chinese middle-aged and elderly populations

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  2. Aspartate aminotransferase is linked with a higher risk of mortality in humans (lowest quintile of AST (8-18 U/L)) (aHR 1.33 (95% CI 1.04-1.70)).

    “For the lowest quintile of AST, only males were at increased risk (aHR 1.33 [95% CI 1.04-1.70]).”

    Humanslowest quintile of AST (8-18 U/L)median 6.4 yearsmalesn = 11,853

    Serum Transaminases and Older Adults: Distribution and Associations With All-Cause Mortality

    The journals of gerontology. Series A, Biological sciences and medical sciences

  3. Aspartate aminotransferase is linked with a higher risk of mortality in humans (patients without cancer in home healthcare) (HR 1.09, 95% CI 1.00-1.18).

    “AST (HR: 1.09; 95% Cl: 1.00 - 1.18)”

    Humanspatients without cancer in home healthcaren = 114

    Prognostic Biomarkers of Mortality in Older Patients Without Cancer in Home Healthcare

    Cureus

  4. Aspartate aminotransferase is associated with mortality in humans (intertrochanteric femoral fractures) (p < 0.05).

    “a lower preoperative AST level was associated with a higher risk of postoperative death (p < 0.05).”

    Humansintertrochanteric femoral fractures

    Two cephalic screws combined compression proximal-femur intramedullary nailing internal fixation versus long-stemmed cemented bipolar hemiarthroplasty for treating intertrochanteric fractures in Patients 75 Years and Older: a retrospective study

    Research SquarePreprint

  5. Aspartate aminotransferase is linked with a higher risk of mortality in humans (adjusted HR 1.02 (95% CI 1.02-1.03)).

    “ALT, AST, and AST/ALT ratio as continuous variables were all associated with mortality (adjusted hazard ratios (95% confidence intervals): 0.98 (0.97−0.99), 1.02 (1.02−1.03), and 1.46 (1.32−1.62), respectively; all p < 0.0001)”

    Humans8 yearsn = 5,958

    High Aspartate Aminotransferase/Alanine Aminotransferase Ratio May Be Associated with All-Cause Mortality in the Elderly: A Retrospective Cohort Study Using Artificial Intelligence and Conventional Analysis

    Healthcare (Basel, Switzerland)

Body mass index

downin humans1mixedin humans1

2 studies
  1. Aspartate aminotransferase is associated with body mass index in humans (β = -0.1869; 95% CI -0.2629 to -0.1109; p < 0.0001).

    “AST showed a significant negative association (β = -0.1869; p < 0.0001; 95% CI: -0.2629 to -0.1109)”

    Humansn = 801

    Effects of smoking on serum biomarkers and their moderation by sex in relation to body mass index

    Biomedica : revista del Instituto Nacional de Salud

  2. Body mass index is associated with aspartate aminotransferase in humans.

    “Serum AST levels showed a J-shaped curve against BMI, whereas ALT and GGT levels showed a linear relationship, regardless of age.”

    Humans

    Elevated serum aspartate aminotransferase levels concomitant with normal alanine aminotransferase levels in older low body weight people: Preliminary findings from a community-based epidemiological study

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Microalbuminuria

upin humans1OR 1.027

1 study
  1. Aspartate aminotransferase is associated with microalbuminuria in humans (OR 1.027 per U/L, 95% CI 1.009–1.046).

    “AST was associated with microalbuminuria (OR 1.027 per U/L, 1.009–1.046), attenuating in parsimonious and outlier-excluded models”

    HumansStrict normotension and ADA-defined prediabetes; association attenuated in parsimonious and outlier-excluded modelsn = 976

    Prevalence and cardiometabolic determinants of subclinical albuminuria in strictly normotensive US adults with prediabetes: an NHANES 2013–2018 analysis

    Diabetes research and clinical practice

More on Microalbuminuria

Log-transformed lipoprotein(a) concentrations

downin humans1

1 study
  1. Aspartate aminotransferase is associated with log-transformed lipoprotein(a) concentrations in humans (20% lower per 1 μkatal/L higher AST (95% CI: 5% to 34%; p=0.012)).

    “HS and higher LFC, ALT and AST were independently associated with lower Lp(a) concentrations in men.”

    Humansserum1 μkatal/L higher ASTmales

    Higher liver fat content is associated with lower lipoprotein(a) concentrations in men and postmenopausal women

    ESC Congress 2026 abstract

More on Log-transformed lipoprotein(a) concentrations

Fezolinetant

upin humans1

1 study
  1. Fezolinetant is associated with aspartate aminotransferase in humans (primary suspect drug in FAERS) (ROR 41.72 (95% CI 34.97-49.76)).

    “aspartate aminotransferase increased (ROR 41.72, 95%CI(ROR): 34.97-49.76, PRR 38.57, 95%CI(PRR): 32.77-45.39)”

    Humansprimary suspect drug in FAERS

    Real-world safety profile of fezolinetant: a disproportionality analysis based on the FAERS database

    Naunyn-Schmiedeberg's archives of pharmacology

More on Fezolinetant

Severe muscle loss

downin humans1OR 0.94

1 study
  1. Aspartate aminotransferase is linked with a lower risk of severe muscle loss in humans (prediabetes) (OR 0.94, 95% CI 0.89-0.99, p=0.04).

    “higher AST levels (0.94, 0.89-0.99;p=0.04) demonstrated significant protective effects.”

    Humansprediabetes3 to 5 yearsn = 199

    Incidence and Predictive Factors of Severe Muscle Loss among Individuals with Prediabetes: A Prospective Cohort Study

    ADA Scientific Sessions 2026 abstract

Gallstones

upin humans1

1 study
  1. Aspartate aminotransferase is linked with a higher risk of gallstones in humans (multivariate logistic regression).

    “Age, waist circumference, aspartate aminotransferase and fasting blood glucose are risk factors for gallstone formation”

    Humansmultivariate logistic regression

    A retrospective observational study: are gallstone patients aging, or are the elderly more susceptible to gallstones?

    BMC gastroenterology

More on Gallstones

Leptin

upin humans1

1 study
  1. Leptin is associated with aspartate aminotransferase in MASLD patients (r = 0.49, p = 0.045).

    “direct correlation was established between leptin level and AST activity (r = 0.49, p = 0.045)”

    Humansin MASLD patients

    Association of Pro- and Anti-Inflammatory Cytokines and Adipokines with Liver Function Parameters and Lipid Profile in Metabolic Dysfunctional-Associated Steatotic Liver Disease Patients of Different Age

    Lviv clinical bulletin

More on Leptin

Cardiovascular disease

upin humans1HR 1.35

1 study
  1. Aspartate aminotransferase raises the risk of cardiovascular disease in humans (HR 1.35 (95% CI: 1.17-1.55)).

    “and 1.35 (95%CI: 1.17-1.55)”

    Review

    The relationship between liver enzymes in the blood test and non-fatal cardiovascular disease events: a systematic review and meta-analysis

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

More on Cardiovascular disease

Lipid accumulation product index

upin humans1

1 study
  1. Lipid accumulation product index is associated with aspartate aminotransferase in humans (obesity and non-alcoholic fatty liver disease) (r=0.223, p=0.009).

    “serum aspartate aminotransferase levels in females (r=0.223 and p=0.009, respectively)”

    Humansobesity and non-alcoholic fatty liver diseasefemales

    Lipid accumulation product (LAP) index and its relation to anthropometric, metabolic and liver function factors in obese patients with NAFLD: a cross-sectional study

    BMJ open

More on Lipid accumulation product index

All 26

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 12Jan 2026: 31Feb 2026: 30Mar 2026: 10Apr 2026: 10May 2026: 10Jun 2026: 8Jul 2026: 13Aug 2026: 8Sep 2026: 11Oct 2026: 23Nov 2026: 21187 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Gene variants linked to higher odds of fatty liver disease

In 402,437 people, variants disrupting one copy of a fat-transport gene were linked to higher fatty liver odds, with an odds ratio of 3.2 versus non-carriers.In 402,437 people, variants disrupting one copy of a fat-transport gene were linked to higher fatty liver odds, with an odds ratio of 3.2 versus non-carriers.

Genetic association · 402,437 peopleMechanisms

See all 502 papers on aspartate aminotransferase